Screener
Bausch Health Companies BHC Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.
The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.
- Filed
- Apr 29, 2026, 6:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885590-26-000053
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest settlements from cross-currency swaps | 5 | 6 |
| Net cash used in investing activities | (139) | (130) |
| Cash Flows From Financing Activities | ||
| Issuance of long-term debt, net of discounts | 2,802 | 50 |
| Repayments of long-term debt | (2,857) | (168) |
| Payments of employee withholding taxes related to share-based awards | (34) | (16) |
| Payments of acquisition-related contingent consideration | (8) | (7) |
| Payments of financing costs | (1) | (5) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch Health Companies's debt issuance proceeds?
- Bausch Health Companies (BHC) reported debt issuance proceeds of $2.8B in Q1 2026.
- How has Bausch Health Companies's debt issuance proceeds changed year-over-year?
- Bausch Health Companies's debt issuance proceeds increased by 5504.0% year-over-year, from $50M to $2.8B.
- What is the long-term trend for Bausch Health Companies's debt issuance proceeds?
- Over 4 years (2021 to 2025), Bausch Health Companies's debt issuance proceeds has grown at a 49.7% compound annual growth rate (CAGR), from $2.1B to $10.56B.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about Bausch Health Companies's debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude